G. Tersalvi, Jeroen Dauw, P. Martens
Jun 3, 2020
Citations
0
Influential Citations
13
Citations
Quality indicators
Journal
Current Heart Failure Reports
Abstract
Purpose of Review To provide pathophysiological and clinical insights into the effects of sacubitril/valsartan on glomerular function. Recent Findings Heart failure and glomerular dysfunction are closely intertwined. In addition to reduced heart failure hospitalization and all-cause mortality, patients treated with sacubitril/valsartan have a slower deterioration of glomerular filtration rate over time compared with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Summary The effects of sacubitril/valsartan are probably mediated through enhancement of natriuretic peptides, reduction of glomerular inflammation and fibrosis, and relaxation of mesangial cells and podocytes. Further studies will elucidate underlying pathophysiological mechanisms of sacubitril/valsartan on glomerular function and their prognostic significance in subjects with and without heart failure.